BEATW

HeartBeam (BEAT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

HeartBeam (BEAT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

LOS ANGELES, CA - May 26, 2026 (NEWMEDIAWIRE) - HeartBeam (NASDAQ: BEAT) is developing technology aimed at improving how cardiac conditions are identified and monitored, positioning its solutions at the intersection of rising clinical need and evolvi...

LOS ANGELES, CA - May 14, 2026 (NEWMEDIAWIRE) - HeartBeam (NASDAQ: BEAT) reported first-quarter 2026 operational and financial results highlighted by the launch of its initial commercial partnerships in key U.S. markets, progress in its heart attack ...

Moby summary of HeartBeam, Inc.'s Q1 2026 earnings call

Moby summary of HeartBeam, Inc.'s Q1 2026 earnings call

HeartBeam, Inc. (BEAT) Q1 2026 Earnings Call May 13, 2026 4:30 PM EDTCompany ParticipantsRobert Eno - CEO, Chief Business Officer & DirectorBryan...

HeartBeam Inc (BEAT) advances its market presence with key partnerships and robust financing, despite early-stage commercialization challenges.

HeartBeam Inc (BEAT) advances its market presence with key partnerships and robust financing, despite early-stage commercialization challenges.

HeartBeam (NASDAQ:BEAT) released first-quarter financial results and hosted an earnings call on Wednesday. Read the complete transcript below. Benzinga APIs provide real-time access to earnings call transcripts and financial data. Visit https://www.benzinga.com/apis/ to learn more. The full earnings call is available at https://viavid.webcasts.com/starthere.jsp?ei=1761581&tp_key=a64f57a332 Summary Heartbeam Inc reported a successful first quarter, with a focus on commercialization and growth ini

HeartBeam (NASDAQ:BEAT) released first-quarter financial results and hosted an earnings call on Wednesday. Read the complete transcript below. Benzinga APIs provide real-time access to earnings call transcripts and financial data. Visit https://www.benzinga.com/apis/ to learn more. The full earnings call is available at https://viavid.webcasts.com/starthere.jsp?ei=1761581&tp_key=a64f57a332 Summary Heartbeam Inc reported a successful first quarter, with a focus on commercialization and growth ini

SANTA CLARA, Calif., May 13, 2026--HeartBeam Reports First Quarter 2026 Results

2026-05-13. The following slide deck was published by HeartBeam, Inc.

LOS ANGELES, CA - May 11, 2026 (NEWMEDIAWIRE) - HeartBeam (NASDAQ: BEAT) announced the initiation of a pilot study evaluating its investigational on-demand 12-lead ECG patch in approximately 50 patients with suspected coronary artery disease at two h...

LOS ANGELES, CA - May 7, 2026 (NEWMEDIAWIRE) - HeartBeam (NASDAQ: BEAT), a medical technology company focused on cardiac care solutions, announced a commercial agreement with Beverly Hills-based concierge medical practice Atelier Health, expanding th...

SANTA CLARA, Calif., May 07, 2026--HeartBeam Expands Commercial Presence Across Four Key U.S. Markets with Addition of Premier Concierge Practice

LOS ANGELES, CA - May 6, 2026 (NEWMEDIAWIRE) - Cardiovascular disease continues to be a major global health challenge, driven by aging populations, lifestyle factors and persistent gaps in early detection that continue to challenge healthcare systems...

LOS ANGELES, CA - April 30, 2026 (NEWMEDIAWIRE) - HeartBeam (NASDAQ: BEAT), a medical technology company focused on cardiac care innovation, will host a conference call on May 13, 2026, at 4:30 p.m. Eastern time to discuss first-quarter results ended...

SANTA CLARA, Calif., April 30, 2026--HeartBeam to Host First Quarter 2026 Results Conference Call on Wednesday, May 13, 2026 at 4:30 p.m. Eastern Time

HeartBeam Inc. (NASDAQ:BEAT) is one of the best NASDAQ growth stocks to buy and hold forever. On April 14, HeartBeam announced the pricing of a $10 million underwritten public offering, consisting of 12,500,000 shares of common stock. The offering is notably led by the company’s first commercial customer, ClearCardio, alongside HeartBeam’s executive leadership, board members, […]